Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Lerer

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
American Journal of Medical Genetics|March 29, 2002
Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophreniaSibylle G Schwab, Joachim Hallmayer, Julia Freimann, et al.
Psychiatry Research|November 19, 2003
Cerebral blood flow in chronic symptomatic mild traumatic brain injuryOmer Bonne, Asaf Gilboa, Yoram Louzoun, et al.
Archives of General Psychiatry|June 6, 2007
Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trialRena Cooper-Kazaz, Jeffrey T Apter, Revital Cohen, et al.
The International Journal of Neuropsychopharmacology|June 1, 2006
Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medicationRael D Strous, Lior Greenbaum, Kyra Kanyas, et al.
Comprehensive Psychiatry|February 17, 2005
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-LMark Weiser, Kyra Kanyas, Dolores Malaspina, et al.
Journal of Molecular Neuroscience : MN|May 14, 2013
Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory studyLior Greenbaum, Stefano Goldwurm, Polina Zozulinsky, et al.
Journal of Psychiatric Research|April 7, 2015
Common variants of IRF3 conferring risk of schizophreniaXiao Li, Wen Zhang, Todd Lencz, et al.
Pharmacogenetics and Genomics|June 15, 2007
Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medicationLior Greenbaum, Rael D Strous, Kyra Kanyas, et al.
Oncogene|September 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Oncogene|March 16, 2023
Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
American Journal of Medical Genetics|March 29, 2002
Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophreniaSibylle G Schwab, Joachim Hallmayer, Julia Freimann, et al.
Psychiatry Research|November 19, 2003
Cerebral blood flow in chronic symptomatic mild traumatic brain injuryOmer Bonne, Asaf Gilboa, Yoram Louzoun, et al.
Archives of General Psychiatry|June 6, 2007
Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trialRena Cooper-Kazaz, Jeffrey T Apter, Revital Cohen, et al.
The International Journal of Neuropsychopharmacology|June 1, 2006
Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medicationRael D Strous, Lior Greenbaum, Kyra Kanyas, et al.
Comprehensive Psychiatry|February 17, 2005
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-LMark Weiser, Kyra Kanyas, Dolores Malaspina, et al.
Journal of Molecular Neuroscience : MN|May 14, 2013
Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory studyLior Greenbaum, Stefano Goldwurm, Polina Zozulinsky, et al.
Journal of Psychiatric Research|April 7, 2015
Common variants of IRF3 conferring risk of schizophreniaXiao Li, Wen Zhang, Todd Lencz, et al.
Pharmacogenetics and Genomics|June 15, 2007
Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medicationLior Greenbaum, Rael D Strous, Kyra Kanyas, et al.
Oncogene|September 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Oncogene|March 16, 2023
Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Pageof 15